| LEXXW Stock | | | USD 0.75 0.04 5.63% |
Lexaria Bioscience financial indicator trend analysis is infinitely more than just investigating Lexaria Bioscience Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lexaria Bioscience Corp is a good investment. Please check the relationship between Lexaria Bioscience Net Income From Continuing Ops and its Ebitda accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
Net Income From Continuing Ops vs Ebitda
Net Income From Continuing Ops vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Lexaria Bioscience Corp Net Income From Continuing Ops account and
Ebitda. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Lexaria Bioscience's Net Income From Continuing Ops and Ebitda is 0.94. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Ebitda in the same time period over historical financial statements of Lexaria Bioscience Corp, assuming nothing else is changed. The correlation between historical values of Lexaria Bioscience's Net Income From Continuing Ops and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Lexaria Bioscience Corp are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Net Income From Continuing Ops i.e., Lexaria Bioscience's Net Income From Continuing Ops and Ebitda go up and down completely randomly.
Correlation Coefficient | 0.94 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Net Income From Continuing Ops
Ebitda
Most indicators from Lexaria Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lexaria Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
At this time, Lexaria Bioscience's
Issuance Of Capital Stock is fairly stable compared to the past year.
Enterprise Value Over EBITDA is likely to climb to 395.77 in 2024, whereas
Selling General Administrative is likely to drop slightly above 2.5
M in 2024.
Lexaria Bioscience fundamental ratios Correlations
Click cells to compare fundamentals
Lexaria Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lexaria Bioscience fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to
measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to
predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.